Effect of chitooligosaccharides on human gut microbiota and antiglycation
Copyright © 2020 Elsevier Ltd. All rights reserved..
Chitooligosaccharides (COS) have garnered great attention in the field of human healthcare. The prebiotic activities and antiglycation of COS were investigated using a combination of in vitro and in vivo studies. COS supplementation dramatically increased the levels of acetic acid, while reducing the concentrations of propionic and butyric acids. It also decreased the total bacterial population; however, it did not affect diversity and richness of the gut microbiota. In addition, COS modulated the gut microbiota composition by increasing Bacteroidetes, decreasing Proteobacteria and Actinobacteria, and lowering the Firmicutes/Bacteroidetes ratio. COS promoted the generation of beneficial Bacteroides and Faecalibacterium genera, while suppressing the pathogenic Klebsiella genus. The antiglycation activity of COS and acetic acid was dose-dependent. Furthermore, COS prevented the decrease of serum Nε-(carboxymethyl) lysine (CML) level caused by CML ingestion in a mouse model of diet-induced obesity. To improve host health, COS could be potential prebiotics in food products.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:242 |
|---|---|
| Enthalten in: |
Carbohydrate polymers - 242(2020) vom: 15. Aug., Seite 116413 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Liu, Wei [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
1398-61-4 |
|---|
| Anmerkungen: |
Date Completed 25.01.2021 Date Revised 04.12.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.carbpol.2020.116413 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM311434835 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM311434835 | ||
| 003 | DE-627 | ||
| 005 | 20231225142241.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.carbpol.2020.116413 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1038.xml |
| 035 | |a (DE-627)NLM311434835 | ||
| 035 | |a (NLM)32564858 | ||
| 035 | |a (PII)S0144-8617(20)30587-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Liu, Wei |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Effect of chitooligosaccharides on human gut microbiota and antiglycation |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 25.01.2021 | ||
| 500 | |a Date Revised 04.12.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2020 Elsevier Ltd. All rights reserved. | ||
| 520 | |a Chitooligosaccharides (COS) have garnered great attention in the field of human healthcare. The prebiotic activities and antiglycation of COS were investigated using a combination of in vitro and in vivo studies. COS supplementation dramatically increased the levels of acetic acid, while reducing the concentrations of propionic and butyric acids. It also decreased the total bacterial population; however, it did not affect diversity and richness of the gut microbiota. In addition, COS modulated the gut microbiota composition by increasing Bacteroidetes, decreasing Proteobacteria and Actinobacteria, and lowering the Firmicutes/Bacteroidetes ratio. COS promoted the generation of beneficial Bacteroides and Faecalibacterium genera, while suppressing the pathogenic Klebsiella genus. The antiglycation activity of COS and acetic acid was dose-dependent. Furthermore, COS prevented the decrease of serum Nε-(carboxymethyl) lysine (CML) level caused by CML ingestion in a mouse model of diet-induced obesity. To improve host health, COS could be potential prebiotics in food products | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a AGEs | |
| 650 | 4 | |a Antiglycation | |
| 650 | 4 | |a Chitooligosaccharides | |
| 650 | 4 | |a Gut microbiota | |
| 650 | 4 | |a Prebiotics | |
| 650 | 4 | |a SCFA | |
| 650 | 7 | |a Oligosaccharides |2 NLM | |
| 650 | 7 | |a oligochitosan |2 NLM | |
| 650 | 7 | |a Chitin |2 NLM | |
| 650 | 7 | |a 1398-61-4 |2 NLM | |
| 650 | 7 | |a Chitosan |2 NLM | |
| 650 | 7 | |a 9012-76-4 |2 NLM | |
| 700 | 1 | |a Li, Xiaoqiong |e verfasserin |4 aut | |
| 700 | 1 | |a Zhao, Zhonglin |e verfasserin |4 aut | |
| 700 | 1 | |a Pi, Xionge |e verfasserin |4 aut | |
| 700 | 1 | |a Meng, Yanyu |e verfasserin |4 aut | |
| 700 | 1 | |a Fei, Dibo |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Daqun |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Xin |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Carbohydrate polymers |d 1994 |g 242(2020) vom: 15. Aug., Seite 116413 |w (DE-627)NLM082819491 |x 1879-1344 |7 nnns |
| 773 | 1 | 8 | |g volume:242 |g year:2020 |g day:15 |g month:08 |g pages:116413 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.carbpol.2020.116413 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 242 |j 2020 |b 15 |c 08 |h 116413 | ||